Singapore to be new headquarters for BlueChilli to build startups in Asia.
Venture studio and innovation group BlueChilli has partnered with Enterprise Singapore, an economic agency under the Singapore Ministry of Trade and Industry, to launch a Singapore-based HealthTech accelerator to spur innovation and build startups that address health challenges and opportunities in Southeast Asia. Singapore is also home to BlueChilli’s new headquarters to build startups in Asia.
The Asia Pacific’s HealthTech sector is the second largest in the world for investment funds raised, only after the USA. Last year, US$6.3 billion was deployed into HealthTech startups in the region. Southeast Asia’s HealthTech ecosystem is still emerging within the region and poised for growth, with Singapore and Indonesia contributing to most of its notable deals in 2018.
They have opened applications for its Singapore-based HealthTech Accelerator, a competitive 6-month venture building programme designed for aspiring and early stage founders in Southeast Asia.
It targets individuals with deep experience and insights in the health sector and who have an idea on how to radically improve health outcomes in the region using technology.
15 founders will be selected for the programme and gain access to BlueChilli’s venture studio to help them build their first product and gain market traction. The founders will get access to tech development services at no additional cost, world-class startup training, seed funding and a global network of advisors and mentors.
Since its establishment in 2012, BlueChilli has built 130+ startups and participated in three exits and one IPO. Startups in its portfolio have collectively raised $170M and contributed to the creation of around 1,000 jobs.
BlueChilli has invested in eight HealthTech companies, including hardware startups BindiMaps.com and Talkiplay.com, mammography AI diagnostics service Alixir.ai, telemedicine platform VetChat.com and out-of-home patient care platform CTARS.com. [APBN]